The Scientific Business of Thomson Reuters Publishes Three Pharma Matters Reports Covering the First Quart... ( Quarterly Reports use Market Intell...)

The Scientific Business of Thomson Reuters Publishes Three Pharma Matters Reports Covering the First Quarter of 2008

Date:8/18/2008

Quarterly Reports use Market Intelligence and Competitive Analysis from Thomson Reuters to Explore Various Aspects of the Pharmaceutical Pipeline

LONDON and PHILADELPHIA, Aug. 18 /PRNewswire/ -- Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, has announced the availability of the Pharma Matters reports covering the time period January-March 2008. Launched more than two years ago, the quarterly Pharma Matters reports cover all aspects of the pharmaceutical pipeline, leveraging strategic intelligence and competitive analysis from Thomson Pharma(R), Newport Horizon Premium(TM) and the Thomson Messaging Mapping System(SM).

The Ones to Watch -- A Thomson Reuters quarterly review of the latest phase changes in the pharmaceutical pipeline, this report is based on the strategic data and analysis from Thomson Pharma, the world's leading pharmaceutical competitive intelligence solution. In the report covering Q1 2008, the top five most promising drugs launched or receiving approval were:

DRUG DISEASE COMPANY

Intelence(TM) HIV-1 infection Tibotec

Pristiq(TM) Depression Wyeth

Ionsys(TM) Acute pain ALZA

Arcalyst(TM) CIAS1-associated Regeneron

periodic syndromes

Moxatag(TM) Streptococcus MiddleBrook

pyogenes-associated

pharyngitis, tonsillitis

More analysis, as well as information on drugs entering clinical Phases I, II and III, are available in the full report: http://scientific.thomsonreuters.com/thomsonpharma/media/pdfs/tpqr/totw_jan -march_08.pdf

(Due to the length of this URL, it may be necessa
'/>"/>

SOURCE Thomson Reuters
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine news :

1. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
2. Thomson Scientific Predicts Nobel Laureates
3. Genaera Announces Formation of Scientific Advisory Board for Obesity Drug Candidate Trodusquemine (MSI-1436)
4. Thomson Scientific Announces BONDplus for Biological Researchers
5. Milestone Scientific Commences Declaratory Judgment Action With Respect to Its Single Tooth Anesthesia (STA(TM)) System and Compudent(TM) System
6. International Society of Hair Restoration Surgery Hosts 15th Annual Scientific Meeting in Las Vegas, September 26-30, 2007
7. Milestone Scientific Names Robert Presutti New Vice President of Sales and Marketing
8. Thomson Scientific Signs Multi-Year Agreement with The Council for Scientific and Industrial Research (CSIR)
9. Heart Failure Society of America 11th Annual Scientific Meeting to Focus on Heart Failure Guidelines, Innovation and New Research
10. Milestone Scientific to Exhibit the STA(TM) System at the American Dental Associations 148th Annual Session in San Francisco
11. Delta Dental Plans Association Forms National Scientific Advisory Committee

Post Your Comments:

(Date:7/12/2014)... York, NY (PRWEB) July 12, 2014 ... steady growth over the past five years, buoyed by ... agricultural sector's supply management system. “Eggs are a relatively ... result, per capita egg consumption generally grows in line ... Industry Analyst Will McKitterick. Furthermore, demand for new specialty ...

(Date:7/12/2014)... 2014 The rise in the number ... new advanced network architectures to suit the upsurge. Virtualization ... with increasing cloud storage technologies. The data traffic has ... mobility devices. This has resulted in larger and more ... forces for the SDN market. , The North American ...

(Date:7/12/2014)... The "North American ... Market by Angioplasty Balloon (Plain/Old, Cutting), ... IVC Filter (Retrievable), Endovascular Stent Graft ... studies the major market drivers, restraints, ... Canada. , Browse 108 market data ...

(Date:7/12/2014)... The Security Analytics market is estimated to ... by 2019, at an expected CAGR of 9.7% for ... counter the increasing number of security breaches, continued line ... systems in organizations are enormous. Vendors in the security ... architecture to develop better and more secure systems. , ...

(Date:7/12/2014)... Melbourne, Australia (PRWEB) July 12, 2014 ... past five years, despite rising competition from international and ... compound annual 2.9% over the five years through 2014-15. ... with consumers demanding more gaming services. Rises in discretionary ... have spent more money on non-essential items such as ...

[0] Chicken Egg Production in Canada Industry Market Research Report Now Available from IBISWorld [0] North America Software Defined Network (SDN) Market Worth $1,443.8 Million by 2019 - New Report by MicroMarket Monitor [0] North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets [0] North America Security Analytics Market Worth $1,215.2 Million by 2019 - New Report by MicroMarket Monitor [0] Casinos in Australia Industry Market Research Report Now Updated by IBISWorld

... Failure by Sutter Medical Center Santa Rosa and Santa ... of county services fuels efforts to make ... SANTA ROSA, Calif., March 12 In the ... workers,at Santa Rosa Memorial Hospital -- already engaged in ...

... show whether an antidepressant is working , , TUESDAY, March ... biomarker for depression that could lead to a quick ... making headway against the disease. , "This may be ... co-author Mark Rasenick, director of the Interdisciplinary Neuroscience Program ...

... study in the,Journal of the American Medical Association ... Staphylococus aureus), a simple,skin or nasal swab, is ... for Methicillin-Resistant Staphylococcus aureus at,Hospital Admission and Nosocomial ... March 12, 2008)., The findings of the ...

... (NYSE:,WLP) announced today that senior management is scheduled to present at ... Healthcare Conference on March 13, 2008, ... Daylight Time (EDT);, -- Lehman Brothers ... March 19, 2008, at 10:15 a.m. EDT., All interested parties ...

... a good news, bad news situation. Some women who ... dont have cancer, they do have atypical hyperplasia -- ... someday. This happens to one-fourth of women undergoing breast ... risk. , In their quest to discover who is ...

... Zimmer Holdings, Inc.,(NYSE ZMH; SWX: ZMH), a leader in the ... upcoming investor,conferences:, -- March 18, 2008 -- Cowen,s ... Massachusetts, 8:00 a.m. Eastern Time -- March 19, 2008 ... Conference, Miami Beach, Florida, 8:30 a.m. Eastern Time, ...

Cached Medicine News:Health News:Santa Rosa Healthcare Workers Seek Accountability From Catholic Hospital System 2 Health News:Scientists Spot Biochemical Sign of Depression 2 Health News:Scientists Spot Biochemical Sign of Depression 3 Health News:JAMA Article Provides False Support for CDC's Do-Nothing Position on MRSA 2 Health News:WellPoint Announces Appearances at Upcoming Conferences 2 Health News:COX-2 expression is marker for cancer development in some benign breast biopsies 2 Health News:COX-2 expression is marker for cancer development in some benign breast biopsies 3 Health News:COX-2 expression is marker for cancer development in some benign breast biopsies 4

Santa Rosa Healthcare Workers Seek Accountability From Catholic Hospital System Scientists Spot Biochemical Sign of Depression JAMA Article Provides False Support for CDC's Do-Nothing Position on MRSA WellPoint Announces Appearances at Upcoming Conferences COX-2 expression is marker for cancer development in some benign breast biopsies Zimmer Holdings to Present at Upcoming Investor Conferences

(Date:7/10/2014)... , July 10, 2014 RESMED INC. (NYSE: ... fourth quarter and fiscal year ended June 30, 2014 results ... Exchange market close. A press release with ResMed,s results will ... company will host a webcast to discuss operating results and ... begin at 1:30 p.m. US Pacific Time and the live ...

(Date:7/10/2014)... 10, 2014 Ventana Medical Systems, Inc. (Ventana), ... has entered into an agreement with Merck KGaA, Darmstadt, ... Serono in the United States ... Merck KGaA,s biopharmaceutical division on the development and commercialization ... using Ventana,s proprietary diagnostic assays. In alignment with Merck ...

(Date:7/10/2014)... 2014 Decision Resources Group finds that over ... Food and Drug Administration,s (FDA) approval of Vifor Fresenius ... was approved by the FDA in November 2013 for ... patients on dialysis. Other key findings from ... 2014 : , ...

Breaking Medicine Technology:ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results 2 Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 2 Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 3 Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2 Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3

[0] ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results [0] Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment [0] Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis

... pleased to announce first quarter 2012 revenues of $210,635, ... The increase in revenues was driven by surgeries at ... using the Kelyniam Custom Skull Implant made from PEEK ... quarter with the new management and a full sales ...

... SNDY) is pleased to announce that the Company has successfully ... $570,000. As a result, the Company expects to achieve a ... financials, and show significant reduction of its liabilities for the ... issued Preferred Stock valued at $10 per share in order ...

Cached Medicine Technology:Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012 2 Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012 3 Solos Endoscopy Reduces Liabilities by More than $570,000 2 Solos Endoscopy Reduces Liabilities by More than $570,000 3

Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012 Solos Endoscopy Reduces Liabilities by More than $570,000

The new XMI catheter incorporates the best in catheter technology to ,provide exceptional handling characteristics comparable to todays balloon catheters and stent delivery systems....

The new XVG catheter is our highest power thrombectomy catheter designed for accessing distal anatomy. Utilizing proprietary Cross-Stream water jet technology, the XVG catheter removes thrombus quick...

Redel Connector 10 Pin...

... a non-fluoroscopic navigation system that tracks multiple ... Fred Wittkampf, Ph.D., and is being developed ... ,The LocaLisa system uses three ... around the heart to track catheters. Using ...

Medicine Products:

XMI Catheter XVG Catheter QWIKCABLE Autoclavable Extension Cable LocaLisa Intracardiac Navigation System